RA Capital Management reports sale of $9.13 million in Lenz Therapeutics common shares

LENZ•2026-11-02

RA Capital Management reported selling 2,718,684 Lenz Therapeutics shares on Oct. 29, 2026, at $3.36 per share. Its indirect beneficial holdings totaled 1,460,139 shares after the transactions.

RA Capital Management reports sale of $9.13 million in Lenz Therapeutics common shares

1. Reported share sale

Related News

Churchill Capital XI shareholders approve deal with Agility Robotics

Pershing Square total AUM ending balance was $32,776 million for three months ended Sept. 30

Crawford & Co Q3 2026 revenue before reimbursements falls to $321.60 million

Sources

RA Capital Management reports sale of $9.13 million in Lenz Therapeutics common shares

Chord Energy grants new CEO Michael H. Lou 6,543 restricted stock units

TOP Ships announces $5 million private placement of convertible notes and warrants